FectoPRO is a transfection reagent specifically optimized for transient protein and antibody expression in CHO and HEK293 cells.

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Meet our Team and registered for our Lunch and Learn Roundtable on Wednesday April 28, 2021 from 1:10 pm - 1:50 pm (EST) !
The current challenges in Gene therapy are increasing viral titer yields, and optimizing the industrial production process of AAVs that are becoming the leading viral vector used to develop Gene therapy. Optimizing key parameters of the upstream process, such as the critical transfection step, can really accelerate the time to market of gene therapies, and in sufficient amount to address diseases with larger patient population or that require bigger doses per patient. Come to discuss with the worldwide leader in transfection Polyplus-transfection during this exciting roundtable.
Roundtable hosted by Julien DEPOLLIER, Director Strategic Partnerships at Polyplus-transfection®.